Deep Science Ventures

Dunia Innovations is pioneering the development of the world's first self-driving laboratory dedicated to electrocatalytic CO2 utilization. The company aims to facilitate the energy transition by addressing challenges in scalable carbon utilization, thereby fostering a circular carbon economy. By transforming carbon dioxide into valuable chemicals and fuels, Dunia Innovations helps businesses understand their carbon footprints and actively contributes to achieving net zero emissions. Through its innovative approach, the company seeks to significantly accelerate catalyst research and optimize processes for effective carbon management.

Neobe Therapeutics provides immunotherapies, clinical trials, research, and tumor-colonizing bacteria engineering services.

Bastion Therapeutics is a preclinical stage biotechnology company focused on developing innovative anti-inflammatory cell therapies. Utilizing its proprietary platform technology, the company aims to enhance regulatory T cells (Tregs) within the immune system. By targeting neuroinflammation in critical areas of the central nervous system, Bastion Therapeutics seeks to protect neurons and improve synaptic connectivity, ultimately helping patients to maintain cognitive function and prevent deterioration. Through its research and development efforts, the company is positioning itself to address significant unmet medical needs in the realm of neuroinflammatory conditions.

Xonai is a software development company that specializes in accelerated computing for data processing platforms. It has developed a fully automated hardware selection and data management platform aimed at creating a universal and flexible infrastructure for cloud computing. Xonai's technology focuses on optimizing data infrastructure to enhance the efficiency of data software, thereby reducing cloud expenses. This enables organizations to scale their data and AI-driven products more effectively, ultimately accelerating their time to value while minimizing costs.

Antiverse is an innovative antibody discovery company that aims to transform drug development by leveraging a unique platform combining structural biology, machine learning, and medicine. The company specializes in predicting antibody-antigen binding and generating antibody drug candidates for challenging targets. By utilizing advanced machine learning techniques and cell-free protein synthesis, Antiverse enables pharmaceutical companies and contract research organizations to accelerate the discovery of antibody hits, ultimately making the drug development process more efficient and cost-effective. Through its commitment to advancing medical science, Antiverse seeks to create meaningful breakthroughs that can significantly impact patient lives.

Rhizocore Technologies specializes in the production of locally-adapted mycorrhizal fungi aimed at improving the success rates of tree planting initiatives. By enhancing the natural symbiotic relationships between plants and fungi, the company enables more efficient woodland regeneration and boosts forest productivity. Its innovative platform addresses the needs of the forestry market, allowing for effective reforestation efforts and contributing to the overall health and sustainability of forest ecosystems.

Holy Grail is a company focused on capturing carbon dioxide from the atmosphere and permanently storing it above ground. It has developed an air carbon capture device that utilizes electrons to extract CO2 from large, centralized emitters. The company is engaged in research, development, and engineering across various technologies, including batteries and catalysts. Additionally, Holy Grail creates material datasets that assist in validating predictions and simulations of experimental data. This enables industrial clients to enhance energy efficiency and economic performance, making significant contributions to carbon reduction efforts.

Concr is a techbio company focused on enhancing cancer treatment through innovative predictive modeling. Utilizing methods derived from astrophysics, Concr aims to accurately forecast patient outcomes and responses to both novel and existing cancer therapies. The company's cloud-native platform, FarrSight®, enables researchers to simulate clinical trials, predict therapeutic responses, and conduct bioinformatics analyses, facilitating a more personalized approach to cancer care. By leveraging fragmented data from various stages of drug development, Concr eliminates the reliance on big data while generating precise multi-modal tumor models. Headquartered in London, with a subsidiary in Brisbane, Australia, Concr is backed by prominent investors, including the University of Cambridge Enterprise and Oncology Ventures, among others.

Mission Zero Technologies specializes in direct air capture technology that efficiently extracts carbon dioxide from the atmosphere. The company's innovative device operates by drawing air, dissolving the carbon dioxide in a water solvent, and subsequently releasing it as gas through an electrodialysis process. This method allows for the production of low-energy, clean carbon dioxide, enabling various sequestration pathways. By providing affordable carbon capture services at any scale, Mission Zero Technologies aims to create environments free from polluted air and contribute to broader efforts in addressing climate change.

Holy Grail is a company focused on capturing carbon dioxide from the atmosphere and permanently storing it above ground. It has developed an air carbon capture device that utilizes electrons to extract CO2 from large, centralized emitters. The company is engaged in research, development, and engineering across various technologies, including batteries and catalysts. Additionally, Holy Grail creates material datasets that assist in validating predictions and simulations of experimental data. This enables industrial clients to enhance energy efficiency and economic performance, making significant contributions to carbon reduction efforts.

Mytos is a company focused on creating a fully automated cell manufacturing platform tailored for the biotechnology sector, particularly in drug development. The platform utilizes advanced automation technology to streamline the production of human cells, allowing pharmaceutical and biotech companies to optimize their cell culture processes. By enabling scientists to easily modify culturing protocols, Mytos facilitates more rapid advancements in cell growth and overall efficiency in research and development. This innovative approach aims to enhance the capabilities of businesses in the drug development industry by providing a sophisticated solution for cell production.

New Motion Labs (NML) is a mechanical engineering intellectual property licensing company based in the United Kingdom. NML specializes in the development and licensing of innovative sprocket tooth profiles designed for sprocket manufacturers. Their proprietary technology, known as Enduo, transforms traditional chain drive systems by facilitating dual point engagement on both sides of the sprocket tooth. This advancement significantly enhances the longevity of conventional chain drives, allowing them to last up to 3.5 times longer and reducing energy losses by 50%. The new tooth profile leads to decreased wear and friction, resulting in a more efficient drivetrain that can be easily retrofitted to existing applications. Through this technology, NML aims to provide users with lightweight and efficient solutions for power transmission.

Beta Bugs is an insect genetics company specializing in the development and distribution of high-performance Black Soldier Fly breeds aimed at enhancing productivity in the insect protein sector. The company operates a breeding program called HiPer-Fly® and maintains a dedicated egg production site known as The Multiplier®, supplying its breeds to both UK and international markets. By focusing on biotechnology and breeding techniques, Beta Bugs aims to create a sustainable protein source that can effectively replace traditional feed ingredients such as fishmeal and soymeal in livestock, aquaculture, and pet feed. Headquartered at the Easter Bush Campus, a recognized center for animal genetics, Beta Bugs collaborates closely with the Roslin Institute, noted for its pioneering work in animal genetics.